2013
DOI: 10.1001/jamaneurol.2013.1342
|View full text |Cite
|
Sign up to set email alerts
|

Risk Factors for β-Amyloid Deposition in Healthy Aging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
147
2
2

Year Published

2013
2013
2020
2020

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 220 publications
(164 citation statements)
references
References 40 publications
9
147
2
2
Order By: Relevance
“…there is elevation of diastolic blood pressure) and later development of AD (61,66,82). Hypertension in cognitively normal adults with at least 1 APOE ϵ4 allele was associated with increased binding of the Aβ tracer F18-labelled florbetapir (116). The conventional interpretation is that hypertension increases the risk of developing AD by promoting the accumulation of Aβ.…”
Section: Therapeutic Implicationsmentioning
confidence: 99%
“…there is elevation of diastolic blood pressure) and later development of AD (61,66,82). Hypertension in cognitively normal adults with at least 1 APOE ϵ4 allele was associated with increased binding of the Aβ tracer F18-labelled florbetapir (116). The conventional interpretation is that hypertension increases the risk of developing AD by promoting the accumulation of Aβ.…”
Section: Therapeutic Implicationsmentioning
confidence: 99%
“…Necroptic studies of patients with AD showed more atherosclerotic lesions in cerebral vessels associated with more amyloid plaques and neurofibrillary tangles [19,20]. Brain of hypertensive patients has increased amyloid plaques and neurofibrillary tangles [21]. Blood β-amyloid (Aβ), involved in the pathogenesis of AD, is elevated in patients with VCI, contributing to vascular dysfunction [22,23].…”
Section: Ad and Htnmentioning
confidence: 99%
“…A study of adults possessing at least one ApoE4 allele revealed that hypertensive individuals tended to have significantly higher Aβ burdens than those with normal blood pressure (Rodrigue et al, 2013). Moreover, cholesterol is involved in generation and deposition of Aβ in the brain, though cholesterol modification Among AChEIs, phenserine, ispronicline and ABT-089 have been tested in patients with AD, but resulted in no significant change in cognitive function (Klein, 2007;Becker and Greig, 2012;NIH, 2011).…”
Section: Modifiable Lifestyle Factors In Admentioning
confidence: 99%